Similar articles

• Stem cell proliferation inhibitors.

  Wright EG, Pragnell IB. Wright EG, et al. Baillieres Clin Haematol. 1992 Jul;5(3):723-39. doi: 10.1016/s0950-3536(11)80014-4. Baillieres Clin Haematol. 1992. PMID: 1457966 Review. No abstract available.
• Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.

  Mayani H, Little MT, Dragowska W, Thornbury G, Lansdorp PM. Mayani H, et al. Exp Hematol. 1995 May;23(5):422-7. Exp Hematol. 1995. PMID: 7536684
• Haemopoietic stem cell inhibition: potential for dose intensification.

  Marshall E. Marshall E. Eur J Cancer. 1995 Sep;31A(10):1586-91. doi: 10.1016/0959-8049(95)00302-y. Eur J Cancer. 1995. PMID: 7488406 Review. No abstract available.
• The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.

  Jacobsen SE, Ruscetti FW, Ortiz M, Gooya JM, Keller JR. Jacobsen SE, et al. Exp Hematol. 1994 Sep;22(10):985-9. Exp Hematol. 1994. PMID: 7522186
• Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.

  Bonnet D, Lemoine FM, Najman A, Guigon M. Bonnet D, et al. Exp Hematol. 1995 Jun;23(6):551-6. Exp Hematol. 1995. PMID: 7539383